Pessaries Market Size, Share & Trends Analysis Report By Type (Gellhorn, Rings, Donuts, Others), By End Use (Hospitals, Clinics, Ambulatory Surgery Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Pessaries Market Size

The global pessaries market size was valued at USD 364.07 million in 2025 and is projected to grow from USD 395.74 million in 2026 to USD 771.35 million by 2034, registering a CAGR of 8.7% during the forecast period from 2026 to 2034. North America dominated the pessaries market with a market share of 41.62% in 2025.

The pessaries market is growing steadily due to rising prevalence of pelvic organ prolapse and stress urinary incontinence among aging female population and increasing preference for non-surgical gynecological management. The market benefits from growing awareness of pelvic floor disorders, especially underdiagnosed conditions that require conservative treatment options. Silicone-based pessaries gain traction due to improved biocompatibility, comfort, and long-term wear ability compared to traditional materials. Clinician-driven fitting practices and outpatient gynecology expansion support adoption across healthcare settings. Rising demand for minimally invasive therapies reduces surgical dependency and strengthens pessary utilization. Integration of telehealth-supported follow-up and digital pelvic health tracking tools improves patient compliance and device management. Expanding geriatric population and increasing focus on quality-of-life improvement continue to drive consistent market growth.

By Type

The ring segment accounted for a dominant share of 56.47% in 2025 due to its high first-fit success rate in mild-to-moderate pelvic organ prolapse, reducing clinical adjustment needs. Its flexible silicone structure ensures better patient comfort during daily activities, improving long-term adherence. Additionally, easy insertion and removal make it widely preferred in outpatient urogynecology settings.

The Gellhorn segment is expected to grow at a CAGR of 4.92% during the forecast period, as it is increasingly preferred for managing moderate to severe pelvic organ prolapse where higher structural support is required. Its rigid dome-and-stem design provides superior retention compared to softer variants, making it suitable for patients with advanced prolapse conditions. Additionally, it is widely used in long-term management cases in urogynecology clinics where surgical options are unsuitable due to comorbidities or high operative risk.

Request Customizationto receive a tailored report.

By End Use

Hospitals accounted for a share of 42.86% of the end-use segment in 2025. This dominance is attributed to the availability of trained urogynecology specialists, ensuring accurate pessary fitting and reduced complications. High inflow of moderate-to-severe pelvic organ prolapse cases and integrated outpatient gynecology units enable same-day fitting, monitoring, and follow-up, making hospitals a preferred care setting.

The clinics segment is projected to grow at a CAGR of 5.15% during the forecast period due to increasing preference for outpatient-based gynecology care that offers faster access and reduced waiting time compared to hospitals. Clinics are expanding dedicated urogynecology services with trained specialists for routine pessary fitting and follow-up management. Rising adoption of nurse-led continence and pelvic health clinics improves patient convenience and drives segment growth.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America: Market Leadership through Specialized Urogynecology Service Networks and Growing Use of Standardized Pessary Usage

The North America pessaries market accounted for a share of 41.62% in 2025, propelled by highly specialized urogynecology service networks and strong penetration of outpatient pelvic floor disorder clinics that standardize conservative prolapse management. Widespread insurance reimbursement for non-surgical pelvic devices further accelerates adoption in clinical practice. Early integration of nurse-led pessary care pathways in women’s health centers improves fitting efficiency and long-term follow-up adherence. High awareness of pelvic health screening programs also enables earlier diagnosis, increasing eligibility for pessary-based treatment across diverse patient groups.

The US market growth is driven by increasing integration of pelvic health into value-based women’s care programs, where hospitals are incentivized to reduce surgical prolapse interventions through effective conservative management. Growth is also driven by large academic medical centers establishing dedicated urogynecology fellowship programs, expanding clinician expertise in pessary fitting and long-term management. The rise of tele-urogynecology consultations enables identification and follow-up of pelvic floor disorders, improving timely pessary adoption.

The Canada pessaries market is supported by increasing inclusion of pelvic floor disorder management within aging-at-home and senior wellness programs, which promotes early use of conservative devices to maintain mobility and quality of life. Growing collaboration between provincial health agencies and women’s health research institutes is improving clinical guidelines for standardized pessary usage across care settings. Strong emphasis on reducing elective gynecological surgery wait times has led hospitals to prioritize pessary-based symptom management, strengthening adoption across public healthcare facilities.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific: Fastest Growth Driven by Improving Product Affordability and Rising Domestic Medical Device Innovation

The Asia Pacific pessaries market is expected to register the fastest growth with a CAGR of 6.20% during the forecast period. This growth is driven by expansion of cost-efficient local manufacturing hubs for gynecological devices, improving product affordability and regional supply chains. Increasing women’s health screening programs in urban primary care settings supports earlier detection of pelvic organ prolapse, boosting conservative treatment use. Rising public-private healthcare collaborations enhance access to urogynecology services in smaller cities, accelerating adoption of pessary-based management across a wider patient base.

The China pessaries market is expanding due to the strong integration of pelvic floor disorder care within rapidly growing tertiary hospital gynecology departments, which are increasingly adopting standardized conservative prolapse management protocols. Rising domestic medical device innovation under national “Made in China” healthcare manufacturing initiatives is improving availability of cost-effective pessaries. Additionally, expanding geriatric women’s health programs driven by aging population policies is increasing clinical focus on non-surgical pelvic support solutions across urban and semi-urban hospitals.

The Singapore pessaries market growth is supported by strong adoption of structured menopause and healthy aging clinics that actively screen and manage pelvic floor disorders as part of preventive women’s health programs. Expansion of same-day gynecology intervention models in public hospitals also supports quick pessary fitting during single outpatient visits, improving patient convenience. High penetration of specialist continence nurse training programs enhances standardized pessary care delivery, ensuring consistent follow-up and reducing variability in device management outcomes across healthcare institutions.

Competitive Landscape

The pessaries market is consolidated, with a few established gynecology-focused medical device companies accounting for a significant share due to strong clinical adoption and long-standing hospital relationships. Leading players such as CooperSurgical, MedGyn Products, Integra LifeSciences, Coloplast, and Wallach Surgical Devices dominate through broad product portfolios and continuous improvements in silicone-based pessary designs. Their strength lies in physician training support, regulatory clearances, and global distribution networks. Smaller and regional manufacturers compete in niche segments with customized designs but face high entry barriers related to clinical validation and limited specialist-driven procurement channels.

List of Key and Emerging Players in Pessaries Market